Evidence map›Paper›PMID 36144661›Full record

ArticleMolecules (Basel, Switzerland)2022

Pharmacological Basis of

Neelum Gul Qazi, Arif-Ullah Khan, Sumra Wajid Abbasi, Fawad Ali Shah, Faisal Rasheed, Fawad Ali, Syed Shams Ul Hassan, Simona Bungau

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pharmacological investigations of newly synthesized oxazolones and imidazolones as COX-2 inhibitors.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Effects ofFrontiers in microbiology · 2024
    Article
  9. Antiulcer Activity of Anthraquinone-Flavonoid Complex ofMolecules (Basel, Switzerland) · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Neelum Gul QaziRiphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad 46000, Pakistan.
Arif-Ullah KhanRiphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad 46000, Pakistan.ORCID 0000-0002-9627-2726
Sumra Wajid AbbasiNums Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Punjab 46000, Pakistan.ORCID 0000-0002-4998-937X
Fawad Ali ShahRiphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad 46000, Pakistan.ORCID 0000-0002-5415-2179
Faisal RasheedBreathMAT Lab., Nuclear Medicine, Oncology and Radiotherapy Institute, Islamabad 45320, Pakistan.ORCID 0000-0002-7703-9443
Fawad AliDepartment of Pharmacy, Kohat University of Science and Technology, Kohat 26000, Pakistan.
Syed Shams Ul HassanShanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.ORCID 0000-0001-5188-6540
Simona BungauDepartment of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania.ORCID 0000-0003-3236-1292
Riphah International University · PKKohat University of Science and Technology · PKNational University of Medical Sciences · PKShanghai Jiao Tong University · CNUniversity of Oradea · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This present study aimed to delineate

Indexed as

Gastrointestinal DiseasesRumexAdenosine TriphosphatasesAnimalsAntidiarrhealsAntioxidantsCalcium Channels, L-TypeCastor OilCharcoalCyclooxygenase 2IsoproterenolJejunumMiceNF-kappa BParasympatholyticsPhytochemicalsAdenosine TriphosphatasesAntidiarrhealsAntioxidantsCalcium Channels, L-TypeCastor OilCharcoalCyclooxygenase 2IsoproterenolNF-kappa BParasympatholyticsPhytochemicalsPlant ExtractsRNA, MessengerRutinTumor Necrosis FactorsVerapamilanti-inflammatoryantioxidantanti-ulcercalcium channelsH+/K+-ATPaseRumex hastatus

Identifiers

PMID36144661
PMCPMC9502566
OpenAlexW4296020536

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.